Learn More
Medchemexpress LLC Cabozantinib | 849217-68-1 | >98% | 500 MG

Supplier: Medchemexpress LLC HY13016500MG
Cabozantinib is a potent and orally active inhibitor of VEGFR2 and MET. It displays strong inhibition of KIT, RET, AXL, TIE2, and FLT3. Cabozantinib shows antiangiogenic activity, disrupts tumor vasculature, and promotes tumor and endothelial cell apoptosis.
- Potent and orally active inhibitor of VEGFR2 and MET
- Displays strong inhibition of KIT, RET, AXL, TIE2, and FLT3
- Shows antiangiogenic activity
- Disrupts tumor vasculature
- Promotes tumor and endothelial cell apoptosis
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.